Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
NBI 35965 is a selective CRF receptor 1 (CRF1) antagonist with a Ki value of 4 nM.1,2 It does not inhibit CRF2 (Ki = >10,000 nM).2 NBI 35965 inhibits cAMP accumulation and adrenocorticotropic hormone (ACTH) production in vitro (pIC50s = 7.1 and 6.9, respectively) and reduces CRF- and stress-induced ACTH production in vivo.3 In animal models of stress, NBI 35965 administration produces anxiolytic effects.2
WARNING This product is not for human or veterinary use.
1. Mechanism of corticotropin-
2. A novel water-
3. Design and synthesis of tricyclic corticotropin-